Bassler M. C. & Stefanakis M. & Sequeira I. & Ostertag E. & Wagner A. & Bartsch J. W. & Roeßler M. & Mandic R. & Reddmann E. F. & Lorenz A. & Rebner K. & Brecht M. (2021) Comparison of Whiskbroom and Pushbroom darkfield elastic light scattering spectroscopic imaging for head and neck cancer identification in a mouse model in: Analytical and Bioanalytical Chemistry (413) 10.1007/s00216-021-03726-5
Betzler A. M. & Nanduri L. K. & Hissa B. & Blickensdörfer L. & Muders M. H. & Roy J. & Jesinghaus M. & Steiger K. & Weichert W. & Kloor M. & Klink B. & Schroeder M. & Mazzone M. & Weitz J. & Reissfelder C. & Rahbari N. N. & Schölch S. (2021) Differential Effects of Trp53 Alterations in Murine Colorectal Cancer in: Cancers (13) 10.3390/cancers13040808
Burstein H. J. & Curigliano G. & Thürlimann B. & Weber W. P. & Poortmans P. & Regan M. M. & Senn H. J. & Winer E. P. & Gnant M. & Panelists of the St Gallen Consensus Conference (2021) Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 in: Annals of Oncology (32) 10.1016/j.annonc.2021.06.023
Coombes R. C. & Tovey H. & Kilburn L. & Mansi J. & Palmieri C. & Bartlett J. & Hicks J. & Makris A. & Evans A. & Loibl S. & Denkert C. & Murray E. & Grieve R. & Coleman R. & Borley A. & Schmidt M. & Rautenberg B. & Kunze C. A. & Rhein U. & Mehta K. & Mousa K. & Dibble T. & Lu X. L. & von Minckwitz G. & Bliss J. M. & Randomized European Celecoxib Trial (REACT) Trial Management Group and Investigators (2021) Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial in: JAMA oncology (7) 10.1001/jamaoncol.2021.2193
Denkert C. & Seither F. & Schneeweiss A. & Link T. & Blohmer J.-U. & Just M. & Wimberger P. & Forberger A. & Tesch H. & Jackisch C. & Schmatloch S. & Reinisch M. & Solomayer E. F. & Schmitt W. D. & Hanusch C. & Fasching P. A. & Lübbe K. & Solbach C. & Huober J. & Rhiem K. & Marmé F. & Reimer T. & Schmidt M. & Sinn B. V. & Janni W. & Stickeler E. & Michel L. & Stötzer O. & Hahnen E. & Furlanetto J. & Seiler S. & Nekljudova V. & Untch M. & Loibl S. (2021) Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials in: The Lancet. Oncology (22) 10.1016/S1470-2045(21)00301-6
Denkert C. & Untch M. & Benz S. & Schneeweiss A. & Weber K. E. & Schmatloch S. & Jackisch C. & Sinn H. P. & Golovato J. & Karn T. & Marmé F. & Link T. & Budczies J. & Nekljudova V. & Schmitt W. D. & Stickeler E. & Müller V. & Jank P. & Parulkar R. & Heinmöller E. & Sanborn J. Z. & Schem C. & Sinn B. V. & Soon-Shiong P. & van Mackelenbergh M. & Fasching P. A. & Rabizadeh S. & Loibl S. (2021) Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy⋆ in: Annals of Oncology (32) 10.1016/j.annonc.2020.12.016
Dubsky P. & Pinker K. & Cardoso F. & Montagna G. & Ritter M. & Denkert C. & Rubio I. T. & de Azambuja E. & Curigliano G. & Gentilini O. & Gnant M. & Günthert A. & Hauser N. & Heil J. & Knauer M. & Knotek-Roggenbauerc M. & Knox S. & Kovacs T. & Kuerer H. M. & Loibl S. & Mannhart M. & Meattini I. & Penault-Llorca F. & Radosevic-Robin N. & Sager P. & Španić T. & Steyerova P. & Tausch C. & Peeters M.-J. T. F. D. V. & Weber W. P. & Cardoso M. J. & Poortmans P. (2021) Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox in: The Lancet. Oncology (22) 10.1016/S1470-2045(20)30580-5
El Bairi K. & Haynes H. R. & Blackley E. & Fineberg S. & Shear J. & Turner S. & de Freitas J. R. & Sur D. & Amendola L. C. et al. (2021) The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group in: NPJ breast cancer (7) 10.1038/s41523-021-00346-1
Erber R. & Hartmann A. & Fasching P. A. & Ruebner M. & Stöhr R. & Beckmann M. W. & Zentgraf M. & Popp V. & Weidler J. & Simon I. & Becker S. & Huebner H. & Fischer J. & Guerini Rocco E. & Viale G. & Cayre A. & Penault-Llorca F. & Caniego Casas T. & Pérez-Miés B. & Palacios J. & Jank P. & Denkert C. & Khoury L. & Mairinger T. & Ferrazzi F. (2021) Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment in: Cancers (13) 10.3390/cancers13184718
Evers M. & Rinke A. & Rütz J. & Ramaswamy A. & Maurer E. & Bartsch D. K. (2021) Prognostic Factors in Curative Resected Locoregional Small Intestine Neuroendocrine Neoplasms in: World Journal of Surgery (45) 10.1007/s00268-020-05884-6
Fasching P. A. & Link T. & Hauke J. & Seither F. & Jackisch C. & Klare P. & Schmatloch S. & Hanusch C. & Huober J. & Stefek A. & Seiler S. & Schmitt W. D. & Uleer C. & Doering G. & Rhiem K. & Schneeweiss A. & Engels K. & Denkert C. & Schmutzler R. K. & Hahnen E. & Untch M. & Burchardi N. & Blohmer J.-U. & Loibl S. & German Breast Group and Arbeitsgemeinschaft Gynäkologische Onkologie Breast (2021) Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study) in: Annals of Oncology (32) 10.1016/j.annonc.2020.10.471
Filho O. M. & Stover D. G. & Asad S. & Ansell P. J. & Watson M. & Loibl S. & Geyer C. E. & Bae J. & Collier K. & Cherian M. & O'Shaughnessy J. & Untch M. & Rugo H. S. & Huober J. B. & Golshan M. & Sikov W. M. & von Minckwitz G. & Rastogi P. & Maag D. & Wolmark N. & Denkert C. & Symmans W. F. (2021) Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial in: JAMA oncology (7) 10.1001/jamaoncol.2020.7310
Furlanetto J. & Marmé F. & Seiler S. & Thode C. & Untch M. & Schmatloch S. & Schneeweiss A. & Bassy M. & Fasching P. A. & Strik D. & Stickeler E. & Schem C. & Karn T. & Grischke E.-M. & Denkert C. & van Mackelenbergh M. & Müller V. & Nekljudova V. & Loibl S. (2021) Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials in: European Journal of Cancer (152) 10.1016/j.ejca.2021.04.038
Ganz H. M. & Buchmann B. & Engelbrecht L. K. & Jesinghaus M. & Eichelberger L. & Gabka C. J. & Schmidt G. P. & Muckenhuber A. & Weichert W. & Bausch A. R. & Scheel C. H. (2021) Generation of ductal organoids from normal mammary luminal cells reveals invasive potential in: The Journal of Pathology (255) 10.1002/path.5790
Gebauer L. & Nist A. & Mernberger M. & Stiewe T. & Moll R. & Stabla K. & Klinge U. & Mack E. & Brendel C. & Neubauer A. (2021) Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors in: Cancers (13) 10.3390/cancers13194959
Groll T. & Schopf F. & Denk D. & Mogler C. & Schwittlick U. & Aupperle-Lellbach H. & Sarker S. R. J. & Pfarr N. & Weichert W. & Matiasek K. & Jesinghaus M. & Steiger K. (2021) Bridging the Species Gap: Morphological and Molecular Comparison of Feline and Human Intestinal Carcinomas in: Cancers (13) 10.3390/cancers13235941
Gross C. & Engleitner T. & Lange S. & Weber J. & Jesinghaus M. & Konukiewitz B. & Muckenhuber A. & Steiger K. & Pfarr N. & Goeppert B. & Keller G. & Weichert W. & Adsay N. V. & Klöppel G. & Rad R. & Esposito I. & Schlitter A. M. (2021) Whole Exome Sequencing of Biliary Tubulopapillary Neoplasms Reveals Common Mutations in Chromatin Remodeling Genes in: Cancers (13) 10.3390/cancers13112742
Hupfer A. & Brichkina A. & Koeniger A. & Keber C. & Denkert C. & Pfefferle P. & Helmprobst F. & Pagenstecher A. & Visekruna A. & Lauth M. (2021) Matrix stiffness drives stromal autophagy and promotes formation of a protumorigenic niche in: Proceedings of the National Academy of Sciences of the United States of America (118) 10.1073/pnas.2105367118
Jesinghaus M. & Schmitt M. & Lang C. & Reiser M. & Scheiter A. & Konukiewitz B. & Steiger K. & Silva M. & Tschurtschenthaler M. & Lange S. & Foersch S. & Becker K. F. & Saur D. & Friess H. & Halfter K. & Engel J. & Boxberg M. & Pfarr N. & Wilhelm D. & Weichert W. (2021) Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases in: The American Journal of Surgical Pathology (45) 10.1097/PAS.0000000000001692
Jurmeister P. & Weber K. & Villegas S. & Karn T. & Untch M. & Thieme A. & Müller V. & Taube E. & Fasching P. & Schmitt W. D. & Marmé F. & Stickeler E. & Sinn B. V. & Jank P. & Schem C. & Klauschen F. & van Mackelenbergh M. & Denkert C. & Loibl S. & Capper D. (2021) DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status in: Clinical Epigenetics (13) 10.1186/s13148-021-01176-5
Kann P. H. & Goebel J. N. & Adelmeyer J. & Bergmann S. & Mann V. & Bartsch D. K. & Holzer K. & Ramaswamy A. & Mahnken A. H. & Leonhardt A. (2021) Endoscopic Ultrasound of the Adrenals in Primary Aldosteronism in: Clinics In Surgery (6)
Kohlruss M. & Krenauer M. & Grosser B. & Pfarr N. & Jesinghaus M. & Slotta-Huspenina J. & Novotny A. & Hapfelmeier A. & Schmidt T. & Steiger K. & Gaida M. M. & Reiche M. & Bauer L. & Ott K. & Weichert W. & Keller G. (2021) Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer in: British Journal of Cancer (125) 10.1038/s41416-021-01587-4
Kohlruss M. & Ott K. & Grosser B. & Jesinghaus M. & Slotta-Huspenina J. & Novotny A. & Hapfelmeier A. & Schmidt T. & Gaida M. M. & Weichert W. & Keller G. (2021) Sexual Difference Matters: Females with High Microsatellite Instability Show Increased Survival after Neoadjuvant Chemotherapy in Gastric Cancer in: Cancers (13) 10.3390/cancers13051048
Konukiewitz B. & Jesinghaus M. & Kasajima A. & Klöppel G. (2021) Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls in: Virchows Archiv 10.1007/s00428-021-03211-5
Konukiewitz B. & Kasajima A. & Schmitt M. & Schwamborn K. & Groll T. & Schicktanz F. & Delbridge C. & Schütze L. M. & Wilhelm D. & Lang C. & Lange S. & Foersch S. & Jank P. & Steiger K. & Werder A. v. & Denkert C. & Weichert W. & Klöppel G. & Jesinghaus M. (2021) Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker? in: Cancers (13) 10.3390/cancers13205111
Konukiewitz B. & Schmitt M. & Silva M. & Pohl J. & Lang C. & Steiger K. & Halfter K. & Engel J. & Schlitter A. M. & Boxberg M. & Pfarr N. & Wilhelm D. & Foersch S. & Tschurtschenthaler M. & Weichert W. & Jesinghaus M. (2021) Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classification in: British Journal of Cancer (125) 10.1038/s41416-021-01553-0
Lebeau A. & Denkert C. (2021) [Updated WHO classification of tumors of the breast: the most important changes] in: Der Pathologe (42) 10.1007/s00292-021-00934-9
Liotta L. & Lange S. & Maurer H. C. & Olive K. P. & Braren R. & Pfarr N. & Burger S. & Muckenhuber A. & Jesinghaus M. & Steiger K. & Weichert W. & Friess H. & Schmid R. & Algül H. & Jost P. J. & Ramser J. & Fischer C. & Quante A. S. & Reichert M. & Quante M. (2021) PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer in: JCI insight (6) 10.1172/jci.insight.141532
Llop-Guevara A. & Loibl S. & Villacampa G. & Vladimirova V. & Schneeweiss A. & Karn T. & Zahm D.-M. & Herencia-Ropero A. & Jank P. & van Mackelenbergh M. & Fasching P. A. & Marmé F. & Stickeler E. & Schem C. & Dienstmann R. & Florian S. & Nekljudova V. & Balmaña J. & Hahnen E. & Denkert C. & Serra V. (2021) Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial in: Annals of Oncology (32) 10.1016/j.annonc.2021.09.003
Loi S. & Michiels S. & Adams S. & Loibl S. & Budczies J. & Denkert C. & Salgado R. (2021) The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition in: Annals of Oncology (32) 10.1016/j.annonc.2021.07.007
Loibl S. & Marmé F. & Martin M. & Untch M. & Bonnefoi H. & Kim S.-B. & Bear H. & McCarthy N. & Melé Olivé M. & Gelmon K. & García-Sáenz J. & Kelly C. M. & Reimer T. & Toi M. & Rugo H. S. & Denkert C. & Gnant M. & Makris A. & Koehler M. & Huang-Bartelett C. & Lechuga Frean M. J. & Colleoni M. & Werutsky G. & Seiler S. & Burchardi N. & Nekljudova V. & von Minckwitz G. (2021) Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial in: Journal of Clinical Oncology (39) 10.1200/JCO.20.03639
Loibl S. & Poortmans P. & Morrow M. & Denkert C. & Curigliano G. (2021) Breast cancer in: Lancet (397) 10.1016/S0140-6736(20)32381-3
Marmé F. & Solbach C. & Michel L. & Schneeweiss A. & Blohmer J.-U. & Huober J. & Fasching P. A. & Jackisch C. & Nekljudova V. & Link T. & Rhiem K. & Rey J. & Denkert C. & Hanusch C. & Tesch H. & Lederer B. & Loibl S. & Untch M. (2021) Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy in: European Journal of Cancer (153) 10.1016/j.ejca.2021.05.027
Matrood S. & Apostolidis L. & Schrader J. & Krug S. & Lahner H. & Ramaswamy A. & Librizzi D. & Kender Z. & Kröcher A. & Kreutzfeldt S. & Gress T. M. & Rinke A. (2021) Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease in: Frontiers in Endocrinology (12) 10.3389/fendo.2021.709256
Metzger-Filho O. & Collier K. & Asad S. & Ansell P. J. & Watson M. & Bae J. & Cherian M. & O'Shaughnessy J. & Untch M. & Rugo H. S. & Huober J. B. & Golshan M. & Sikov W. M. & von Minckwitz G. & Rastogi P. & Li L. & Cheng L. & Maag D. & Wolmark N. & Denkert C. & Symmans W. F. & Geyer C. E. & Loibl S. & Stover D. G. (2021) Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness in: NPJ breast cancer (7) 10.1038/s41523-021-00349-y
Möbus V. & Lück H.-J. & Ladda E. & Klare P. & Schmidt M. & Schneeweiss A. & Grischke E.-M. & Wachsmann G. & Forstbauer H. & Untch M. & Marmé F. & Blohmer J.-U. & Jackisch C. & Huober J. & Stickeler E. & Reinisch M. & Link T. & Sinn B. V. & Janni W. & Denkert C. & Furlanetto J. & Engels K. & Solbach C. & Schmatloch S. & Rey J. & Burchardi N. & Loibl S. & GBG and AGO-B (2021) Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2) in: European Journal of Cancer (156) 10.1016/j.ejca.2021.07.033
Nielsen T. O. & Leung S. C. Y. & Rimm D. L. & Dodson A. & Acs B. & Badve S. & Denkert C. & Ellis M. J. & Fineberg S. & Flowers M. & Kreipe H. H. & Laenkholm A.-V. & Pan H. & Penault-Llorca F. M. & Polley M.-Y. & Salgado R. & Smith I. E. & Sugie T. & Bartlett J. M. S. & McShane L. M. & Dowsett M. & Hayes D. F. (2021) Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group in: Journal of the National Cancer Institute (113) 10.1093/jnci/djaa201
Noske A. & Ammann J. U. & Wagner D.-C. & Denkert C. & Lebeau A. & Sinn P. & Kreipe H.-H. & Sommer U. & Baretton G. & Steiger K. & Kiechle M. & Hieke-Schulz S. & Flores M. & Roth W. & Weichert W. (2021) A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer in: Histopathology (78) 10.1111/his.14254
Pfefferle P. I. & Keber C. U. & Cohen R. M. & Garn H. (2021) The Hygiene Hypothesis - Learning From but Not Living in the Past in: Frontiers in Immunology (12) 10.3389/fimmu.2021.635935
Priedigkeit N. & Ding K. & Horne W. & Kolls J. K. & Du T. & Lucas P. C. & Blohmer J.-U. & Denkert C. & Machleidt A. & Ingold-Heppner B. & Oesterreich S. & Lee A. V. (2021) Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences in: Breast cancer research (23) 10.1186/s13058-020-01379-3
Repenning A. & Happel D. & Bouchard C. & Meixner M. & Verel-Yilmaz Y. & Raifer H. & Holembowski L. & Krause E. & Kremmer E. & Feederle R. & Keber C. U. & Lohoff M. & Slater E. P. & Bartsch D. K. & Bauer U.-M. (2021) PRMT1 promotes the tumor suppressor function of p14ARF and is indicative for pancreatic cancer prognosis in: The EMBO journal (40) 10.15252/embj.2020106777
Riecke K. & Müller V. & Weide R. & Schmidt M. & Park-Simon T.-W. & Möbus V. & Mundhenke C. & Polasik A. & Lübbe K. & Hesse T. & Laakmann E. & Thill M. & A Fasching P. & Denkert C. & Fehm T. & Nekljudova V. & Rey J. & Loibl S. & Witzel I. (2021) Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores in: Cancers (13) 10.3390/cancers13040844
Romero-Olmedo A. J. & Schulz A. R. & Huber M. & Brehm C. U. & Chang H.-D. & Chiarolla C. M. & Bopp T. & Skevaki C. & Berberich-Siebelt F. & Radbruch A. & Mei H. E. & Lohoff M. (2021) Deep phenotypical characterization of human CD3+ CD56+ T cells by mass cytometry in: European Journal of Immunology (51) 10.1002/eji.202048941
Safai Zadeh E. & Beutel B. & Dietrich C. F. & Keber C. U. & Huber K. P. & Görg C. & Trenker C. (2021) Perfusion Patterns of Peripheral Pulmonary Lesions in COVID-19 Patients Using Contrast-Enhanced Ultrasound (CEUS): A Case Series in: Journal of Ultrasound in Medicine (40) 10.1002/jum.15624
Safai Zadeh E. & Westhoff C. C. & Keber C. U. & Trenker C. & Dietrich C. F. & Alhyari A. & Mohr C. G. L. & Görg C. (2021) Perfusion Patterns of Peripheral Organizing Pneumonia (POP) Using Contrast-Enhanced Ultrasound (CEUS) and Their Correlation with Immunohistochemically Detected Vascularization Patterns in: Diagnostics (11) 10.3390/diagnostics11091601
Schmitt M. & Silva M. & Konukiewitz B. & Lang C. & Steiger K. & Halfter K. & Engel J. & Jank P. & Pfarr N. & Wilhelm D. & Foersch S. & Denkert C. & Tschurtschenthaler M. & Weichert W. & Jesinghaus M. (2021) Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups in: Cancers (13) 10.3390/cancers13246177
Schrodi S. & Braun M. & Andrulat A. & Harbeck N. & Mahner S. & Kiechle M. & Klein E. & Schnelzer A. & Schindlbeck C. & Bauerfeind I. & Schubert-Fritschle G. & Nekljudova V. & Mayr D. & Weichert W. & Denkert C. & Loibl S. & Engel J. (2021) Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort in: Annals of Oncology (32) 10.1016/j.annonc.2021.08.1988
Sinn B. V. & Loibl S. & Hanusch C. A. & Zahm D.-M. & Sinn H.-P. & Untch M. & Weber K. & Karn T. & Becker C. & Marmé F. & Schmitt W. D. & Müller V. & Schem C. & Treue D. & Stickeler E. & Klauschen F. & Burchardi N. & Furlanetto J. & van Mackelenbergh M. & Fasching P. A. & Schneeweiss A. & Denkert C. (2021) Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer in: Clinical Cancer Research (27) 10.1158/1078-0432.CCR-20-3113
Striefler J. K. & Riess H. & Lohneis P. & Bischoff S. & Kurreck A. & Modest D. P. & Bahra M. & Oettle H. & Sinn M. & Bläker H. & Denkert C. & Stintzing S. & Sinn B. V. & Pelzer U. (2021) Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study in: Frontiers in Oncology (11) 10.3389/fonc.2021.670396
Stürken C. & Möbus V. & Milde-Langosch K. & Schmatloch S. & Fasching P. A. & Rüschoff J. & Stickeler E. & Henke R.-P. & Denkert C. & Hanker L. & Schem C. & Vladimirova V. & Karn T. & Nekljudova V. & Köhne C.-H. & Marmé F. & Schumacher U. & Loibl S. & Müller V. (2021) TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer in: BMC cancer (21) 10.1186/s12885-021-08656-0
Stürznickel J. & Jähn-Rickert K. & Zustin J. & Hennig F. & Delsmann M. M. & Schoner K. & Rehder H. & Kreczy A. & Schinke T. & Amling M. & Kornak U. & Oheim R. (2021) Compound Heterozygous Frameshift Mutations in MESD Cause a Lethal Syndrome Suggestive of Osteogenesis Imperfecta Type XX in: Journal of Bone and Mineral Research (36) 10.1002/jbmr.4277
Terrisse S. & Derosa L. & Iebba V. & Ghiringhelli F. & Vaz-Luis I. & Kroemer G. & Fidelle M. & Christodoulidis S. & Segata N. & Thomas A. M. & Martin A.-L. & Sirven A. & Everhard S. & Aprahamian F. & Nirmalathasan N. & Aarnoutse R. & Smidt M. & Ziemons J. & Caldas C. & Loibl S. & Denkert C. & Durand S. & Iglesias C. & Pietrantonio F. & Routy B. & André F. & Pasolli E. & Delaloge S. & Zitvogel L. (2021) Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment in: Cell Death and Differentiation (28) 10.1038/s41418-021-00784-1
Van Bockstal M. R. & Cooks M. & Nederlof I. & Brinkhuis M. & Dutman A. & Koopmans M. & Kooreman L. & van der Vegt B. & Verhoog L. & Vreuls C. & Westenend P. & Kok M. & van Diest P. J. & Nauwelaers I. & Laudus N. & Denkert C. & Rimm D. & Siziopikou K. P. & Ely S. & Zardavas D. & Roberts M. & Floris G. & Hartman J. & Acs B. & Peeters D. & Bartlett J. M. S. & Dequeker E. & Salgado R. & Giudici F. & Michiels S. & Horlings H. & van Deurzen C. H. M. (2021) Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group in: Cancers (13) 10.3390/cancers13194910
Villegas S. L. & Nekljudova V. & Pfarr N. & Engel J. & Untch M. & Schrodi S. & Holms F. & Ulmer H. U. & Fasching P. A. & Weber K. E. & Albig C. & Heinrichs C. & Marmé F. & Hartmann A. & Hanusch C. & Schmitt W. D. & Huober J. & Lederer B. & van Mackelenbergh M. & Tesch H. & Jackisch C. & Rezai M. & Sinn P. & Sinn B. V. & Hackmann J. & Kiechle M. & Schneeweiss A. & Weichert W. & Denkert C. & Loibl S. (2021) Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials in: European Journal of Cancer (148) 10.1016/j.ejca.2021.02.020
Wächter S. & Di Fazio P. & Maurer E. & Manoharan J. & Keber C. & Pfestroff A. & Librizzi D. & Bartsch D. K. & Luster M. & Eilsberger F. (2021) Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target? in: Cancers (13) 10.3390/cancers13225688
Wagner B. R. & Adamus A. L. & Sönnecken D. & Vahdad R. & Jank P. & Denkert C. & Mahnken A. H. & Seitz G. (2021) Establishment of a new valid animal model for the evaluation of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric rhabdomyosarcoma in: Pediatric Blood & Cancer (68) 10.1002/pbc.29202
Welz L. & Kakavand N. & Hang X. & Laue G. & Ito G. & Silva M. G. & Plattner C. & Mishra N. & Tengen F. & Ogris C. & Jesinghaus M. & Wottawa F. & Arnold P. & Kaikkonen L. & Stengel S. & Tran F. & Das S. & Kaser A. & Trajanoski Z. & Blumberg R. & Roecken C. & Saur D. & Tschurtschenthaler M. & Schreiber S. & Rosenstiel P. & Aden K. (2021) Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis in: Gastroenterology (162) 10.1053/j.gastro.2021.09.057
Westhoff C. C. & Peterlein C.-D. & Daniel H. & Paletta J. R. & Moll R. & Ramaswamy A. & Lakemeier S. (2021) Expression of Estrogen Receptor Alpha and Evaluation of Histological Degeneration Scores in Fibroblasts of Hypertrophied Ligamentum Flavum: A Qualitative Study in: Biomolecules (11) 10.3390/biom11121752
Willvonseder B. & Stögbauer F. & Steiger K. & Jesinghaus M. & Kuhn P.-H. & Brambs C. & Engel J. & Bronger H. & Schmidt G. P. & Haller B. & Weichert W. & Keller G. & Noske A. & Pfarr N. & Boxberg M. (2021) The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations in: Cancer immunology, immunotherapy (70) 10.1007/s00262-020-02813-3